US FDA approves obesity drug Wegovy which helped people cut
Dr. B.P RAHUL
US FDA approves obesity drug Wegovy which helped people cut weight by 15%. All you need to know

According to the US Food and Drug Administration (FDA), the safety and efficacy of Wegovy, a higher-dose version of Novo Nordisk’s diabetes drug semaglutide, were studied in four 68-week trials.

The US Food and Drug Administration (FDA) on Friday approved a new version of popular diabetes medicine to be sold as a weight-loss drug in the United States. In addition to a reduced-calorie diet and increased physical activity, the doctors will now be ableto prescribe injectable drug Wegovy, a higher-dose version of Novo Nordisk’s diabetes drug semaglutide, for chronic weight management.
https://www.hindustantimes.com/world-news/us-fda-approves-obesity-drug-wegovy-safety-efficacy-and-side-effects-of-higher-version-semaglutide-101622902273350.html
Dr. k●●●●i p●●●l and 11 others like this1 share
Like
Comment
Share
Dr. M●●●●●●d Q●●●●●●i
Dr. M●●●●●●d Q●●●●●●i General Medicine
Good share Thanks
Jun 7, 2021Like1
Dr. M●●●●●●d Q●●●●●●i
Dr. M●●●●●●d Q●●●●●●i General Medicine
Good share Thanks
Jun 7, 2021Like2